Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse
Top Cited Papers
- 1 March 2000
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 2 (2) , 128-134
- https://doi.org/10.1002/(sici)1521-2254(200003/04)2:2<128::aid-jgm95>3.0.co;2-w
Abstract
Background Several nonviral vectors including linear polyethylenimine(L‐PEI) confer a pronounced lung tropism to plasmid DNA when injected into the mouse tail vein in a nonionic solution. Methods and results We have optimized this route by injecting 50 µg DNA with excess L‐PEI (PEI nitrogen/DNA phosphate=10) in a large volume of 5% glucose (0.4 ml). In these conditions, 1–5% of lung cells were transfected (corresponding to 2 ng luciferase/mg protein), the other organs remaining essentially refractory to transfection (1–10 pg luciferase/mg protein).β‐Galactosidase histochemistry confirmed alveolar cells, including pneumocytes, to be the main target, thus leading to the puzzling observation that the lung microvasculature must be permeable to cationic L‐PEI/DNA particles of ca 60 nm. A smaller injected volume, premixing of the complexes with autologous mouse serum, as well as removal of excess free L‐PEI, all severely decreased transgene expression in the lung. Arterial or portal vein delivery did not increase transgene expression in other organs. Conclusions These observations suggest that effective lung transfection primarily depends on the injection conditions: the large nonionic glucose bolus prevents aggregation as well as mixing of the cationic complexes and excess free L‐PEI with blood. This may favour vascular leakage in the region where the vasculature is dense and fragile, i.e. around the lung alveoli. Cationic particles can thus reach the epithelium from the basolateral side where their receptors (heparan sulphate proteoglycans) are abundant. Copyright © 2000 John Wiley & Sons, Ltd.Keywords
This publication has 43 references indexed in Scilit:
- In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vectorProceedings of the National Academy of Sciences, 1997
- In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexesGene Therapy, 1997
- Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 1997
- Improved DNA: liposome complexes for increased systemic delivery and gene expressionNature Biotechnology, 1997
- Factors influencing the efficiency of cationic liposome-mediated intravenous gene deliveryNature Biotechnology, 1997
- Stabilization of cationic liposome‐plasmid DNA complexes by polyamines and poly(ethylene glycol)‐phospholipid conjugates for efficient in vivo gene deliveryFEBS Letters, 1997
- In Vivo Gene Transfer by Intravenous Administration of Stable Cationic Lipid/DNA ComplexPharmaceutical Research, 1997
- A New Cationic Liposome DNA Complex Enhances the Efficiency of Arterial Gene Transfer In VivoHuman Gene Therapy, 1996
- Pharmacokinetics, Tissue Distribution, and Expression Efficiency of Plasmid [33P]DNA Following Intravenous Administration of DNA/Cationic Lipid Complexes in Mice: Use of a Novel Radionuclide ApproachJournal of Pharmaceutical Sciences, 1996
- Systemic gene therapy: biodistribution and long-term expression of a transgene in mice.Proceedings of the National Academy of Sciences, 1995